CenterBook Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$585K Buy
+3,281
New +$536K 0.03% 601
2023
Q1
– Sell
-9,722
Closed -$264K – 415
2022
Q4
$264K Buy
+9,722
New +$445K 0.04% 348

Other funds holding GH

CenterBook Partners's GH Position: Q3 2026 in Review

CenterBook Partners opened a new position in Guardant Health (GH) in Q3 2026: 3,281 shares worth $585K. The stake represents 0.03% of the portfolio and ranks #601 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in GH as recently as Q4 2022.

CenterBook Partners first reported a position in GH in Q4 2022 and has held it in 2 quarters since. 676 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • CenterBook Partners held 3,281 shares of Guardant Health worth $585K as of Q3 2026.
  • Guardant Health was a new CenterBook Partners position in Q3 2026.
  • Guardant Health made up 0.03% of CenterBook Partners's portfolio in Q3 2026, its #601 holding.
  • CenterBook Partners first reported a position in Guardant Health in Q4 2022 and has held it in 2 quarters since.
  • 676 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.